• Investing
  • Stock
  • Editor’s Pick
  • Economy
The Significant Deals
Stock

B. Riley shares climb on reports of Great American unit sale to Oaktree

by October 14, 2024
written by October 14, 2024

Investing.com — Investment bank B. Riley Financial Inc (NASDAQ:RILY) has agreed to sell its appraisal and valuations unit to asset manager Oaktree Capital for around $386 million, according to media reports.

B. Riley is due to receive around $203 million in cash, as well as preferred equity units in a new holding company for the unit — known as Great American Group — worth roughly $183 million, the reports added. The deal is tipped to close before the end of the year, reports said.

B. Riley has been moving to offload assets as part of a bid to raise cash to help it contend with a $2 billion debt pile and an investigation by the US Securities and Exchange Commission into its operations.

Shares in B. Riley, which had previously said it was in negotiations over the sale of a part of its stake in Great American, surged by more than 20% in premarket US trading on Monday.

However, the stock has fallen by more than 81% so far this year.

Monday’s reports come after B. Riley had earlier warned that its exposure to Vitamin Shoppe-owner Franchise Group (NASDAQ:FRG) may lead to a write-down and losses in its second quarter.

Delays in finalizing the valuations of some loans and investments also forced the B. Riley to push back the filing of its quarterly report with regulators.

Meanwhile, co-founder Bryant Riley has put forward a take-private offer for the broker-dealer, arguing that being a public company has forced it to focus on “short-term objectives” and allocate time and attention to “constituencies who are not aligned with the owners of the business,” Reuters reported.

(Reuters contributed to this report.)

This post appeared first on investing.com
0 comment
0
FacebookTwitterPinterestEmail

previous post
beaconsmind Group Enhances WiFi in German Shopping Centers
next post
Elliott requests special meeting with Southwest Airlines, Bloomberg News reports

You may also like

BASF results down on impairments, restructuring

January 27, 2025

European chipmakers slump as traders gauge DeepSeek AI...

January 27, 2025

Nasdaq futures tumble as China’s AI push rattles...

January 27, 2025

China Vanke’s CEO, chairman resign amid growing liquidity...

January 27, 2025

Fuji Media, rocked by sexual misconduct allegations, says...

January 27, 2025

Italy’s MPS shares fall ahead of Mediobanca board...

January 27, 2025

British Land stock drops following stake sale

January 27, 2025

UMG shares rally after new multi-year pact with...

January 27, 2025

BASF shares indicated 3% lower as impairments drag...

January 27, 2025

Ryanair cuts 2026 traffic forecast amid ongoing Boeing...

January 27, 2025
Sign up and get the scoop before anyone else—fresh updates, and secret deals, all wrapped up just for you. We're talking juicy tips, fun surprises, and invites to events you actually want to go to. Don’t just watch from the sidelines—jump in and be part of the magic!








    By signing up, you're cool with getting emails from us. Don’t worry — your info stays safe, sound, and strictly confidential. No spam, no funny business. Just the good stuff.

    Recent Posts

    • Elon Musk’s SpaceX acquires xAI

      February 25, 2026
    • The architect of Amazon’s supply chain on running a startup with your spouse

      February 25, 2026
    • Trump administration alleges Nike discriminated against white workers

      February 25, 2026
    • Landmark trial accusing social media companies of addicting children to their platforms begins

      February 25, 2026

    Categories

    • Economy (245)
    • Editor's Pick (3,646)
    • Investing (688)
    • Stock (6,426)

    Latest News

    • Elon Musk’s SpaceX acquires xAI
    • The architect of Amazon’s supply chain on running a startup with your spouse

    Popular News

    • Fifth Third Bancorp’s profit falls on higher loan loss provisions
    • Novo Nordisk shares plunge after CagriSema obesity drug trial disappoints

    About The Significant deals

    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Copyright © 2026 thesignificantdeals.com | All Rights Reserved

    The Significant Deals
    • Investing
    • Stock
    • Editor’s Pick
    • Economy